Search Results
97 items found for "acid-base"
- Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice
) are proton-activated G protein-coupled receptors that are stimulated upon increased extracellular acidity These receptors have various physiological and pathophysiological roles in renal acid-base physiology , Nicole Joller , Carsten A Wagner , Pedro Henrique Imenez Silva Tags G-protein-coupled receptors , acid-base
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
difficult highlighting an urgent need for new biomarkers that distinguish ductal carcinomas on this basis For baseline phenotypic characterization, blood gas analysis showed no differences in blood pH, blood demonstrated no differences in fluid intake, urine volume, urinary pH or urine osmolality between genotypes in baseline will be useful to delineate the collecting duct-specific role of GPR56 for renal function, including acid-base sodium/hydrogen exchanger 3 in the intestine and kidneys for fluid and electrolyte homeostasis and acid-base
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
Oncology and Immunology GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic A defining hallmark of GBM is a highly acidic tumor microenvironment, which is thought to activate pro-tumorigenic Notably GPR68, an acid sensing GPCR, is upregulated in radioresistant GBM. identified in a non-biased zebrafish embryonic development screen and validated with Morpholino and CRISPR based demonstrate how glioblastoma cells acidify their microenvironment to activate the commonly over expressed acid
- From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction
News < GPCRs in Oncology and Immunology From outside to inside and back again: the lysophosphatidic acid-CCN Lysophosphatidic acid (LPA) is a lipid that activates G protein-coupled receptors (GPCRs), enhancing
- High Metabolite Concentrations in Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases
Published date November 20, 2023 Abstract "We show that the gut bacterial metabolites, short chain fatty acids affecting peripheral immune cells, and consequently Western lifestyle diseases, most of which are immune based Charles R Mackay Tags Gut microbiota , Western lifestyle diseases , portal vein , short chain fatty acids
- Signaling by Neutrophil G Protein-Coupled Receptors that Regulate the Release of Superoxide Anions
and mitochondrial protein synthesis and recognized by formyl peptide receptors (FPRs) and free fatty acids recognized by free fatty acid receptors (FFARs) regulate neutrophil functions. Short peptides and short chain fatty acids activate FPR1 and FFA2R, respectively, while longer peptides and fatty acids activate FPR2 and GPR84, respectively.
- Ep 50 with Dr. Thomas P. Sakmar
initially focused on structure-activity relationships underlying spectral tuning and identified a glutamic acid residue in rhodopsin that serves as the retinylidene Schiff base counterion. Tom’s lab also developed an amber codon suppression method to genetically encode unnatural amino acids The genetic code expansion strategy for unnatural amino acid mutagenesis is a key enabling technology
- A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages
Furthermore, metabolomic analysis revealed alterations in carboxylic acids, fatty acids, and amino acids
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
Likewise, lysophosphatidic acid receptor 1 (LPA1) is implicated in cancer cell proliferation and migration The addition of lysophosphatidic acid (LPA) further hindered CXCL12-induced Gαi/o recruitment to CXCR4 protein-coupled receptor , GPCR heteromer , GPCR signaling , Inflammatory disease , Lysophosphatidic acid
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR We have decoded the mechanisms underlying recognition of fish oil (unsaturated fatty acids) and other Metabolism 2023), recognition of amine containing hormones by GPCRs (Cell 2021, 2023, Nature 2023b), bile acids
- Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis
established that activation of the GPCR OXER1 by its natural agonist, the eicosanoid 5-oxo-eicosatetraenoic acid We also observed PTX-dependent TNT biogenesis in response to lysophosphatidic acid (LPA), indicative
- TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling
site-directed mutagenesis, we established that Gαi interacted with TNFAIP8 through its C terminal amino acids , and that TIPE2 protein interacted with PIP2 and PIP3 through its positively charged amino acids on
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
Candidate expression was evaluated in mice with UUO or diabetes or injected with adriamycin or folic acid cells accumulated in the kidneys of mice with UUO or diabetes or injected with adriamycin or folic acid
- Ep 44 with Dr. Steven Foord
identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic, and nicotinic acid
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
performed; protein-protein interaction (PPI) mechanisms were explored; hub genes and micro ribonucleic acid CCR3), CCR7, frizzled homolog 5 (FZD5), metabotropic glutamate receptor 8 (GRM8), hydroxycarboxylic acid A clinical prediction model on the basis of GPCR-related risk scores was constructed.
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
Nitric acid (NO) inhibition was tested on the macrophage cell line RAW264.7. An experiment-based network reflected a pharmacological relationship between Jinqiancao granules and
- Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
We studied CXCL10(1-73), lacking the four endmost C-terminal amino acids, which was previously identified The production of CXCL10(1-73) was optimized through Fmoc-based solid phase peptide synthesis (SPPS)
- Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation
Here we report on the systematic analysis of public ribonucleic acid-sequencing (RNA-seq) gene expression selection of samples, therefore, supporting and emphasising the need for the future development of case-to-case
- Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses in sterile and infectious inflammation
GPR101 mediates the phagocyte-directed pro-resolving activities of RvD5n-3 DPA (n-3 docosapentaenoic acid-derived
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
Network pharmacology analysis identified six herbal compounds-ampelopsin, ellagic acid, colchicine, epigallocatechin
- Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
Previous studies have identified the pivotal role of Lysophosphatidic acid (LPA)-signaling in ovarian
- GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
GPCRs in Oncology and Immunology GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based
- Dr. GPCR Summit 2021 Live Talks
John Streicher September 13, 2021 at 9:00:00 PM Learn More >> Through the Looking-Glass: Structure-Based David Gloriam September 15, 2021 at 6:00:00 PM Learn More >> Hydroxycarboxylic acid receptor 3 and GPR84 basic and translational research Evi Kostenis September 17, 2021 at 5:00:00 PM Learn More >> Molecular basis
- Structure-based discovery of functionally selective 5-HT1A receptor agonists
Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Structure-based
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
receptor 2 , Provocative concentration causing a 20% drop in forced expiratory volume in 1 second from baseline , Prurigo nodularis , SP , STAT , Sialic-acid-binding immunoglobulin-like lectin 8 , Signal transducer
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
The cleaved BAI1 isoform has a 19 amino acid extracellular stalk that can serve as a receptor agonist while the alternative transcripts generate BAI1 isoforms with extracellular N-termini of 5 or 60 amino acids demonstrated that kidney-specific Adgrf5/Gpr116 knockout causes luminal membrane accumulation of V-ATPase in acid-secreting
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based Differentially expressed (DE) genes between experimental groups were characterized based on RNA-seq and
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
< GPCR News < GPCRs in Oncology and Immunology Structural Basis for the Recognition of GPRC5D by Talquetamab GPRC5D complexed with the Fab fragment of talquetamab, using cryo-electron microscopy, providing the basis